Morrisons takeover bid: supermarket is an attractive target for private-equity buyers
A private-equity group has made an offer for Morrisons, Britain’s fourth-largest supermarket. Other bids are likely to emerge. Matthew Partridge reports.
Shares in Wm Morrison, Britain’s fourth-largest supermarket, surged by 30% on Monday following a takeover approach from US private-equity firm Clayton, Dubilier & Rice (CD&R), says Jonathan Eley in the Financial Times. CD&R’s 230p-a-share offer gives Wm Morrison an enterprise value of £8.7bn. It has rejected the approach, claiming it “significantly undervalued” its business and prospects.
The only surprise about CD&R’s approach “is that it has taken so long for a bidder to emerge”, say Andrea Felsted and Chris Hughes on Bloomberg. This is because pandemic shopping habits, combined with “lacklustre” share-price performances, have made grocers “alluring buys”.
What’s more, Wm Morrison has “all the ingredients” to be an “attractive” target, with “almost £5.8bn of freehold property” on its books, compared with the pre-bid market capitalisation of £4.3bn. And relations between management and the current shareholders are troubled, as the management has been criticised for receiving lavish pay despite “poor” stockmarket returns.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Who will gatecrash the party?
It’s true that the bid comes at a moment of “heightened tension” between Wm Morrison’s board and its investors, says Simon Duke in The Times. Governance is regarded as a “festering sore” after two of its independent directors quit amid concerns over “perceived chumminess” in the firm’s top ranks, while a “multimillion-pound bonus” for CEO David Potts led to “one of the largest pay revolts on record”. Despite this bad blood, however, shareholders seem to be sticking by the current team. Legal & General, a top-ten shareholder, has come out in support of the decision to send CD&R “packing”.
Not so fast, says Ben Marlow in The Daily Telegraph. While the board technically rejected the offer, its response was relatively “meek”. Certainly there was nothing in it to suggest that “this is a company that is about to fight tooth and nail for its independence”. Instead, it implicitly left the door “wide open” for the private-equity firm to return with a higher offer and indeed “for others to gatecrash the party”. Alternative bidders could include other buyout firms, such as Lone Star and Apollo.
Morrisons’ board “has a point”, as CD&R can certainly afford to “dig a lot deeper”, says Aimee Donnellan on Breakingviews. Analysts expect Wm Morrison to boost sales by 3% a year over the next three years, as well as lift its EBITDA margin above 6%. This means CD&R could earn a “respectable” 17% internal rate of return on its investment without making many changes to the group’s business. Indeed, if it managed to boost Wm Morrison’s EBITDA margins to 7.5% – “the same as Tesco is expected to earn in 2024” – it could “afford to pay more than 300 pence per share and still book a 20% return”.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Live: Did UK inflation rise in December? What to expect from tomorrow’s report
December’s inflation report will be published at 7.00am tomorrow. The team at MoneyWeek is reporting live.
By Katie Williams Last updated
-
Newspaper baron David Montgomery to bid for The Telegraph
Veteran media mogul David Montgomery has seen off a bid for his media group National World. But he now has his eye on The Telegraph
By Jane Lewis Published
-
Why Wise could be worth a lot more than its share price implies
Foreign-exchange transfer service Wise has the potential to become the Amazon of its sector – here's why you should consider buying this stock now
By Jamie Ward Published
-
Can The Gym Group pump up your portfolio?
Gym Group was one of the best UK small-cap stocks in 2024 and will beef up your profits this New Year
By Rupert Hargreaves Published
-
MoneyWeek's five predictions for investors in 2025
MoneyWeek's City columnist gazes into his crystal ball and sees five unexpected events in store for investors in 2025
By Matthew Lynn Published
-
How buy-and-build stocks deliver strong returns
Bunzl, DCC and Diploma became successful through buy-and-build – rolling up dozens of unglamorous businesses. How does it work and what makes it successful?
By Jamie Ward Published
-
Singapore Technologies Engineering shows strong growth
Singapore Technologies Engineering offers diversification, improving profitability and income
By Dr Mike Tubbs Published
-
Royal Mail takeover by Czech billionaire approved for £3.6bn
Royal Mail is now owned by Czech billionaire Daniel Kretinsky, following a £3.6 billion takeover
By Dr Matthew Partridge Published
-
AstraZeneca goes cheap – should you buy?
The decline in AstraZeneca’s share price is overdone given the outlook, and the stock is cheap
By Rupert Hargreaves Published
-
Why undersea cables are under threat – and how to protect them
Undersea cables power the internet and are vital to modern economies. They are now vulnerable
By Simon Wilson Published